The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
Visualización o descarga de ficheros![](/xmlui/themes/Mirage2//images/despl_contenidos.png)
Visualización o descarga de ficheros
Fecha de publicación
2015Título de revista
BIOMARKERS
Tipo de contenido
Artigo
MeSH
Acute-Phase Proteins | Animals | Biomarkers | Humans | Inflammation | Inflammation Mediators | Lipocalin-2 | Lipocalins | Metabolic Diseases | Predictive Value of Tests | Prognosis | Proto-Oncogene Proteins | AdipokinesResumen
Lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), is a secreted glycoprotein that belongs to a group of transporters of small lipophilic molecules in circulation. LCN2 has been recently characterized as an adipose-derived cytokine. This adipokine is believed to bind small substances, such as steroids and lipopolysaccharides, and has been reported to have roles in the induction of apoptosis in hematopoietic cells, transport of fatty acids and iron, modulation of inflammation, and metabolic homeostasis. Recently, LCN2 has emerged as a useful biomarker and rheumatic diseases. This review provides an overview of LCN2 in inflammation, immunity, and metabolism.
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives License
![](/xmlui/themes/Mirage2//images/final_lines.png)